Patents by Inventor Panduranga Adulla P. Reddy

Panduranga Adulla P. Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for the treatment of inflammatory disorders and microbial diseases
    Patent number: 7553864
    Abstract: This invention relates to compounds of the Formulae (I)-(IX): or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, aggrecanase, ADMP, LpxC, ADAMs, TACE, TNF-? or combinations thereof.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: June 30, 2009
    Assignee: Schering Corporation
    Inventors: M. Arshad Siddiqui, Umar Faruk Mansoor, Panduranga Adulla P. Reddy, Vincent S. Madison
  • Imidazopyrazines as protein kinase inhibitors
    Patent number: 7511040
    Abstract: In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or Aurora kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or Aurora kinases using such compounds or pharmaceutical compositions.
    Type: Grant
    Filed: November 7, 2007
    Date of Patent: March 31, 2009
    Assignee: Schering Corporation
    Inventors: David B. Belanger, M. Arshad Siddiqui, Timothy J. Guzi, Patrick J. Curran, Praveen K. Tadikonda, Blake Hamann, Panduranga Adulla P. Reddy, Lianyun Zhao
  • HYDANTOIN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS
    Publication number: 20080226618
    Abstract: This invention relates to compounds of the Formula (I), or a pharmaceutically acceptable salt, solvate, ester or isomer thereof, which is useful for the treatment of diseases or conditions mediated by LpxC.
    Type: Application
    Filed: August 29, 2007
    Publication date: September 18, 2008
    Inventors: Umar Faruk Mansoor, Panduranga Adulla P. Reddy, M. Arshad Siddiqui
  • IMIDAZOPYRAZINES AS PROTEIN KINASE INHIBITORS
    Publication number: 20080139571
    Abstract: In its many embodiments, the present invention provides a novel class of imidazopyrazine compounds as inhibitors of protein and/or Aurora kinases, methods of preparing such compounds, pharmaceutical compositions including one or more such compounds, methods of preparing pharmaceutical formulations including one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the protein or Aurora kinases using such compounds or pharmaceutical compositions.
    Type: Application
    Filed: November 7, 2007
    Publication date: June 12, 2008
    Inventors: David B. Belanger, M. Arshad Siddiqui, Timothy J. Guzi, Patrick J. Curran, Praveen K. Tadikonda, Blake Hamann, Panduranga Adulla P. Reddy, Lianyun Zhao